Related Experiment Videos
Cyclosporin A does not increase the oxidative susceptibility of low density lipoprotein in vitro
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235-9073, USA.
Insights
Cyclosporin A (CsA) does not directly promote low-density lipoprotein (LDL) oxidation. This study found no significant effect of CsA on LDL oxidation in various in vitro systems, suggesting it is not a pro-oxidant.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Research
Background:
- Accelerated atherosclerosis is a major complication in renal transplant recipients.
- The exact mechanisms driving atherosclerosis progression in these patients remain unclear.
- Cyclosporin A (CsA), an immunosuppressant, is suspected to increase low-density lipoprotein (LDL) susceptibility to oxidation.
Purpose of the Study:
- To investigate the in vitro effect of Cyclosporin A (CsA) on low-density lipoprotein (LDL) oxidation.
- To determine if CsA directly contributes to the oxidative modification of LDL.
Main Methods:
- LDL was incubated with varying concentrations of CsA.
- LDL oxidation was assessed using three distinct systems: copper-dependent, AAPH-initiated (metal-independent), and macrophage-mediated oxidation.
- LDL alpha-tocopherol levels were also measured after CsA pre-incubation.
Main Results:
- Cyclosporin A (CsA) demonstrated no significant impact on LDL oxidation across all tested systems (copper-dependent, AAPH-initiated, macrophage-mediated).
- Pre-incubation of LDL with CsA did not alter the rate of LDL oxidation.
- CsA did not affect LDL alpha-tocopherol levels, indicating no direct pro-oxidant effect.
Conclusions:
- Cyclosporin A (CsA) does not appear to be a direct pro-oxidant agent concerning LDL oxidation.
- The findings suggest that CsA's role in accelerated atherosclerosis in renal transplant recipients may not be mediated by direct LDL oxidation.
Abstract:
Accelerated atherosclerosis is the leading cause of morbidity in renal transplant recipients. The pathogenic mechanisms responsible for the progression of atherosclerosis in renal transplant recipients have not been elucidated. Cyclosporin A (CsA) is an immunosuppressive agent used post-transplant and may contribute to increased oxidative susceptibility of low density lipoprotein (LDL). There is a paucity of data testing the effect of CsA on LDL oxidation. Hence, the aim of this study was to test the effect of in vitro enrichment of LDL with CsA on LDL oxidation. LDL oxidation in presence of different concentrations of CsA was tested using metal-dependent (copper), metal-independent (AAPH) and cell-mediated (macrophages) oxidation systems. In all 3 systems, CsA had no significant effect on LDL oxidation. Also, pre-incubation of LDL with CsA did not affect LDL oxidation and LDL alpha tocopherol levels. Thus, the results of our studies with CsA indicate that it is not a direct pro-oxidant.